Consensus and controversies in platelet transfusion: trigger for indication, and platelet dose

Area of Science:

• Hematology
• Transfusion Medicine

Background:

• Platelet transfusion, a therapy for nearly 50 years, still has undefined clinical use aspects.
• Key areas lacking definitive evidence include transfusion thresholds and optimal platelet doses.

Purpose of the Study:

• To review current evidence on platelet transfusion triggers and doses.
• To highlight the need for further research in optimizing platelet transfusion protocols.

Main Methods:

• Review of existing literature on prophylactic and therapeutic platelet transfusion triggers.
• Identification of ongoing clinical trials addressing platelet dose and transfusion thresholds.

Main Results:

• Evidence supports a prophylactic platelet transfusion trigger of 10 x 10(9)/L for most patients.
• A consensus exists to maintain platelet counts above 50 x 10(9)/L in patients with acute bleeding.
• Optimal therapeutic transfusion triggers and platelet doses are not yet established.

Conclusions:

• Further research, including results from ongoing NIH and BEST Collaborative Group trials, is crucial for defining effective platelet transfusion strategies.
• Clearer guidelines are needed for both prophylactic and therapeutic platelet transfusions to improve patient outcomes.